跳至主要内容
临床试验/ACTRN12624000015549
ACTRN12624000015549招募中Unknown

Application of indocyanine green in gastric and oesophageal cancer patients (ICG-GO): Investigating the impact on quality of surgery

Peter MacCallum Cancer Centre0 个研究点目标入组 40 人开始时间: 2024年1月10日最近更新:
适应症

试验速览

阶段
Unknown
状态
招募中
发起方
入组人数
40

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional
分配方式
Non-randomised trial
主要目的
Treatment
盲法
Open (masking not used)

入排标准

年龄范围
18 Years 至 o limit(—)
性别
All

入选标准

  • 1.Patients with cancers of the oesophagus, gastro-oesophageal junction and stomach who are undergoing curative-intent surgery.
  • 2.Patients undergoing the following operations:
  • Ivor-Lewis (two-stage) oesophagectomy
  • McKeown (three-stage) oesophagectomy
  • Proximal partial oesophago-gastrectomy
  • Extended total gastrectomy
  • Total gastrectomy
  • Subtotal gastrectomy

排除标准

  • 1.Patient declined participation in study
  • 2.Known allergy to indocyanine green, sodium iodide or iodine.
  • 3.Evidence of thyroid nodules on physical examination or on standard of care staging PET/CT scan
  • 4.Biochemical evidence of hyperthyroidism from thyroid function tests (TFT)
  • 5.Patient’s receiving concurrent radioactive iodine treatment for thyroid disease
  • 6.Patients with Stage IV cancer (AJCC 8th edition)
  • 7.Stage IV and V kidney failure
  • 8.Pregnancy and breastfeeding

研究者

发起方
Peter MacCallum Cancer Centre

相似试验